JinkoSolar Announces Fourth Quarter and Full Year 2020 Financial Results
News provided by
Share this article
Share this article
SHANGRAO, China, April 9, 2021 /PRNewswire/ JinkoSolar Holding Co., Ltd. ( JinkoSolar or the Company ) (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2020.
Strategic Business Updates
Despite extreme challenges, we experienced significant growth in both revenues and shipments for the full year compared with 2019.
As of the end of 2020, JinkoSolar became the world s largest PV manufacturer, with aggregate module of 70GW. We expect shipments to sustain a growth rate of over 30% in 2021.
Ionis prices private placement of convertible senior notes
News provided by
Share this article
Share this article
CARLSBAD, Calif., April 8, 2021 /PRNewswire/ Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today the pricing of $550.0 million aggregate principal amount of 0% Convertible Senior Notes due 2026 (the notes ) in a private placement (the offering ) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the Securities Act ). The aggregate principal amount of the offering was increased from the previously announced offering size of $500.0 million. Ionis also granted the initial purchasers of the notes an option to purchase, within the 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $82.5 million aggregate principal amount of notes from Ionis. The sale of the notes is expected to close on April 12, 2021, subject to customary closing conditions.
(IONS) - Ionis Axes Akcea s 70% Workforce Under Restructuring Plan benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Ionis announces proposed private placement of convertible notes
News provided by
Share this article
Share this article
CARLSBAD, Calif., April 6, 2021 /PRNewswire/ Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it intends to offer, subject to market conditions and other factors, $500.0 million aggregate principal amount of Convertible Senior Notes due 2026 (the notes ) in a private placement (the offering ) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the Securities Act ). Ionis also intends to grant the initial purchasers of the notes an option to purchase, within the 13-day period beginning on, and including, the first date on which the notes are issued, up to an additional $75.0 million principal amount of notes.
Share this article
Share this article
SAN FRANCISCO, April 5, 2021 /PRNewswire/ Invitae (NYSE: NVTA), a leading medical genetics company, today announced that a small group of investors, led by SB Management, a subsidiary of Softbank Group Corp., will make an investment of $1.15 billion in convertible senior notes to support the Company s future growth initiatives. Invitae s mission is to deliver genetic information to improve healthcare for billions of people at all stages of life. With the support of our long-term shareholders, we re creating the platform to support the routine use of genetics in mainstream medicine to result in better healthcare for everyone, said Sean George, co-founder and chief executive officer of Invitae. This investment will help us continue to fuel our growth, including expanding our platform, services and menu through both in-house development and the addition of complementary companies and technologies as we work to build a differentiated platfo